Related Experiment Video
Updated: Jan 29, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Implementation and Evaluation of a Diabetic Ketoacidosis Order Set in Pediatric Type 1 Diabetes at a Tertiary Care
Kayla Flood1, Munier Nour1, Tanya Holt1
1Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; Royal University Hospital, Saskatoon, Saskatchewan, Canada.
Insights
A new diabetic ketoacidosis (DKA) order set improved pediatric DKA management in a tertiary hospital. The evidence-based protocol led to better fluid, potassium, and dextrose administration, increasing clinical uptake and enhancing patient care.
Area of Science:
- Pediatric Endocrinology
- Clinical Protocol Development
- Healthcare Quality Improvement
Background:
- Published guidelines for pediatric diabetic ketoacidosis (DKA) management exist, yet a standardized protocol was lacking in our center.
- This gap highlighted the need for an evidence-informed approach to improve DKA care for pediatric patients.
Purpose of the Study:
- The primary objective was to achieve widespread clinical adoption of a DKA order set.
- Secondary aims focused on enhancing standard-of-care principles for fluid, potassium, and dextrose administration in pediatric DKA.
Main Methods:
- A multidisciplinary team was formed to review evidence and develop a DKA order set.
- A modified plan-do-study-act cycle, incorporating end-user feedback and outcome data, facilitated iterative improvements and hospital-wide implementation.
Main Results:
- The DKA order set achieved 83% uptake in the tertiary center and 67% for transferred patients.
- Significant improvements were observed in IV fluid rates, earlier potassium administration and dosing, and timely IV dextrose addition.
Conclusions:
- Implementing a DKA order set requires stakeholder engagement, a multidisciplinary team, and robust evaluation.
- The study demonstrated increased physician order-set uptake and improved DKA management practices, with plans for broader implementation and resource utilization analysis.
Objectives:
Despite published clinical practice guidelines in pediatrics for the use of a standardized diabetic ketoacidosis (DKA) protocol, our centre lacked an accepted, evidence-informed protocol for pediatric DKA management. Our primary aim was to attain broad clinical uptake of a DKA order set. Secondary aims included improved standard-of-care DKA management principles regarding fluid, potassium and dextrose administration.
Methods:
A pediatric multidisciplinary collaborative was created to examine evidence for the development and implementation of a DKA order set. A modified plan-do-study-act cycle guided by end-user feedback and early clinical outcomes allowed progressive order-set modifications and hospitalwide implementation.
Results:
We achieved 83% uptake of the order set for patients presenting to our tertiary centre and 67% uptake for patients transferred from peripheral centres. Following the implementation of the DKA order set, we observed improvements in DKA management, which included more appropriate intravenous (IV) replacement fluid rates (30% vs. 55.1%; p=0.03); earlier administration of potassium to IV fluids (66% vs. 93.1%; p=0.006); more appropriate potassium chloride dosing to IV fluid (40% vs. 79.3%; p=0.0007) and earlier addition of IV dextrose (67.4% vs. 93.1%; p=0.009).
Conclusions:
Implementation of a DKA order set in a tertiary hospital required identification of key stakeholders, formation of a multidisciplinary team and the development of an evaluation process. There was an observed increase in physician order-set uptake and DKA management practice improvements. Future goals involve expanding the implementation and evaluation process to provincial regional and remote centres and analyzing the impact on resource utilization.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Specialized Care Centers and Settings-II
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...

